Adaptive Biotechnologies Corporation
ADPT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $48 | $65 | $90 | $139 |
| Short-Term Investments | $174 | $281 | $408 | $214 |
| Receivables | $42 | $38 | $40 | $17 |
| Inventory | $8 | $14 | $14 | $19 |
| Other Curr. Assets | $11 | $11 | $9 | $13 |
| Total Curr. Assets | $284 | $410 | $562 | $403 |
| Property Plant & Equip (Net) | $94 | $120 | $164 | $173 |
| Goodwill | $119 | $119 | $119 | $119 |
| Intangibles | $3 | $5 | $7 | $9 |
| Long-Term Investments | $34 | $0 | $0 | $217 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $5 | $7 | $4 | $3 |
| Total NC Assets | $256 | $251 | $294 | $521 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $539 | $661 | $857 | $923 |
| Liabilities | – | – | – | – |
| Payables | $7 | $8 | $8 | $3 |
| Short-Term Debt | $10 | $9 | $9 | $5 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $56 | $49 | $64 | $80 |
| Other Curr. Liab. | $25 | $22 | $28 | $25 |
| Total Curr. Liab. | $98 | $88 | $110 | $114 |
| LT Debt | $79 | $89 | $99 | $107 |
| Deferred Rev, NC | $27 | $45 | $59 | $99 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $132 | $131 | $125 | $0 |
| Total NC Liab. | $239 | $265 | $283 | $205 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $89 | $99 | $108 | $112 |
| Total Liabilities | $337 | $353 | $393 | $319 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$1,304 | -$1,144 | -$919 | -$719 |
| AOCI | $0 | $0 | -$4 | -$1 |
| Other Equity | $1,506 | $1,453 | $1,387 | $1,324 |
| Total Equity | $203 | $308 | $464 | $604 |
| Supplemental Information | – | – | – | – |
| Minority Interest | -$0 | -$0 | -$0 | $0 |
| Total Liab. & Tot. Equity | $539 | $661 | $857 | $923 |
| Net Debt | $41 | $34 | $18 | -$27 |